WuXi AppTec Co., Ltd. (HKG: 2359)
Hong Kong
· Delayed Price · Currency is HKD
52.80
-0.35 (-0.66%)
Jan 3, 2025, 4:08 PM HKT
WuXi AppTec Revenue
WuXi AppTec had revenue of 10.46B CNY in the quarter ending September 30, 2024, a decrease of -1.96%. This brings the company's revenue in the last twelve months to 38.50B, down -4.94% year-over-year. In the year 2023, WuXi AppTec had annual revenue of 40.34B with 2.51% growth.
Revenue (ttm)
38.50B CNY
Revenue Growth
-4.94%
P/S Ratio
n/a
Revenue / Employee
936.41K CNY
Employees
41,116
Market Cap
159.63B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.34B | 986.03M | 2.51% |
Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
Dec 31, 2019 | 12.87B | 3.26B | 33.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
CSPC Pharmaceutical Group | 33.53B |